Doctor160

Shenzhen, China Founded: 2009 • Age: 17 yrs Listed
Doctor appointment booking tool

About Doctor160

Doctor160 is a publicly listed company based in Shenzhen (China) founded in 2009. Doctor appointment booking tool. Its website 91160.com draws about 151 thousand monthly visits. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Appointment Booking. Its competitors include Soyoung, Haodf and Mingyizhudao; 3 of its 3 listed competitors have raised funding.

Company details

Doctor160 was founded in 2009 in Shenzhen, China, operating as a healthcare platform focused on hospital reservations and medical services. Appointment registration, management, online payments, inspection reports, post-consultation follow-ups, and user surveys are provided. Doctor ratings and medical information are also accessible. As of July 2015, around 330,000 doctors and 30 million users were registered on the domain 91160.com.

  • Headquarters Shenzhen, China
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health
  • Website 91160.com
  • Legal Name 160 Health International Ltd.
Key Metrics
  • Annual Revenue
    $90.82 M (USD)
    5.05
    as on Dec 31, 2025
  • Net Profit
    -$10.17 M (USD)
    32.21
    as on Dec 31, 2025
  • EBITDA
    -$6.39 M (USD)
    41.79
    as on Dec 31, 2025
  • Latest Funding Round
    $8.2M (USD), Post-IPO

    Nov 2016

  • Investors

Funding Insights of Doctor160

  • Total Rounds 1
  • Last Round Post-IPO β€” $8.2M
  • First Round $8.2M

    (Nov 2016)

  • Investors Count 2

All 1 funding rounds of Doctor160 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2016$8.2MPost-IPO––
Valuation history

2 investors in total: 2 institutional.

Investors in Doctor160

Doctor160 has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Qifu Capital and ABC Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are managed by Qifu Capital.
2013qfvc.cnSanya, China
A leading platform for venture capital and equity investment is operated.
abccapital.cnChina
Premium access

Investor details for Doctor160

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of Doctor160

Doctor160 is a publicly listed company on the HKEX with ticker symbol 2656 in Hong Kong, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date17 Sep 2025
  • Listed onHKG: 2656
  • Listed entity160 Health International Ltd.
  • Exchange sectorDistribution services
  • ISINKYG6S54B1005
  • Share price2.82 HKD (-1.91% on the day) · 2026-10-14
  • Market capitalisation998,316,727.00 HKD
  • EPS (diluted, trailing year)-0.18 HKD
  • Volume (last session)54,817,500

Financials of Doctor160

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025707.0M HKD-79.2M HKD-49.8M HKD
2024673.0M HKD-116.8M HKD-85.5M HKD
2023694.6M HKD-125.8M HKD-75.6M HKD
2022611.3M HKD-129.4M HKD-68.4M HKD
Premium access

Detailed financial statements for Doctor160

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Doctor160

3 dated milestones of Doctor160 across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Doctor160 is founded.
  2. Funding First funding round of $8.2M.
  3. IPO Lists on the stock exchange (IPO).

Competitors of Doctor160

Doctor160 has 3 listed competitors in our database, 3 of them funded. They include Soyoung, Haodf and Mingyizhudao.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
soyoung.com2013Beijing, China$200M
Online platform to book doctors for cosmetic health
haodf.com2006Beijing, China$263.39M
Doctor appointments and medical news are provided online by Haodf.
mingyizhudao.com2014Shanghai, China$33.25M
O2O platform to book surgeons
Premium access

Detailed competitors of Doctor160

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Doctor160

The website of Doctor160 (91160.com) receives about 150.5K visits a month and ranks #142,695 among all websites worldwide, #4,358 in Health.

  • Monthly visits
    150.5K

    ▲ 3.6% vs previous month

  • Unique visitors
    78K

    per month

  • Global rank
    #142,695

    among all websites

  • Category rank
    #4,358

    Health · Health

Similar websites

Websites whose visitors overlap most with Doctor160. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
mingyihui.net
100%
#306,301View details
guahao.com
guahao.com
88%
#342,559–
yihu.com
85%
48.3K#493,941View details
236z.com
236z.com
84%
#727,862–
guahaoe.com
guahaoe.com
84%
#1,225,748–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Doctor160

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Doctor160

Doctor160 was founded in 2009 and raised its 1st funding round 7 years after it was founded.

Doctor160 is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Annual revenue of Doctor160 is $90.82M as on Dec 31, 2025.

Doctor160 was founded in 2009 in Shenzhen, China, operating as a healthcare platform focused on hospital reservations and medical services. Appointment registration, management, online payments, inspection reports, post-consultation follow-ups, and user surveys are provided. Doctor ratings and medical information are also accessible. As of July 2015, around 330,000 doctors and 30 million users were registered on the domain 91160.com.

Doctor160's top competitors include Soyoung, Haodf and Mingyizhudao.

Yes, Doctor160 is publicly traded on HKEX under the ticker symbol 2656.

Doctor160 has 2 investors. Key investors include Qifu Capital, and ABC Capital.

The website of Doctor160 receives about 151 thousand visits a month and ranks #142,695 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available